• Published On: February 10, 2020
    New CE mark approval

    10MD gains market access for the new product MindPeace.

  • Published On: November 21, 2019
    Texray presented at Heart-live in Stuttgart

    Heartlive is the annual congress for interventional heart medicine within the German Cardiac Society. It is designed and organized by universities, hospitals and established physicans. It is a well-attended meeting with a high number of live cases and many didactically prepared cases. Congress attendees had the opportunity to test HeadPeace and sign up for the new product, MindPeace (patent pending, 10MD, Sweden), as soon it will become available on the European market.

  • Published On: November 21, 2019
    Scientific presentation of HeadPeace

    A clinical study shows that all absorbed radiation doses on the left side of the head were statistically reduced by HeadPeace.

  • Published On: November 21, 2019
    Abstract – based on Sahlgrenska university hospital and 10MD phantom study to measure reduction of radiation exposure 10MD novel products

    - Accepted and presented at LINC 2020.

  • Published On: November 14, 2019
    BIBA Medical acknowledges TeXray

    BIBA Medical was able to catch Petra during a busy schedule to see how launching the TeXray material on the CX Innovation platform was a great foundation to start executing...

  • Published On: September 30, 2019
    10MD announces election of new Board of Directors

    The shareholders of 10MD have elected Mrs Pernilla Linden and Mr Mats Alm as directors of the Board in order to strengthen and prepare the company for the market launch of HeadPeace and MindPeace.

  • Published On: September 10, 2019
    Successful verification of MindPeace in Europe

    Experienced doctors acknowledged the added value of MindPeace - a new 10MD product, which expands 10MD's portfolio of products based on TeXray.

  • Published On: July 10, 2019
    Decision to grant 10MD patent in Europe

    10MD is delighted to announce that a Decision to Grant has been received from the European Patent Agency regarding the patent EP 2.981.975 and that national publications shall be assigned shortly.

  • Published On: June 24, 2019
    CE mark applications submitted to regulatory authorities

    HeadPeace will soon be accompanied by three additional products in the 10MD product portfolio based on the world's first radiation protection textile, TeXray.

  • Published On: June 18, 2019
    10MD continues to build Intellectual properties

    10MD has recently filed another patent application for the company's next product line. The patent family constitutes an innovative product line focusing on the reduction of radiation exposure for doctors, nurses and technicians throughout the global market.